Laia Miralles - Search Results

Year	Number of Results
2009	2
2011	2
2015	1
2016	2
2017	4
2018	1
2021	3
2023	1
2026	0

1

Feasibility of using monocyte-derived dendritic cells obtained from cryopreserved cells for DC-based vaccines.

Usero L, Miralles L, Esteban I, Pastor-Quiñones C, Maleno MJ, Leal L, García F, Plana M. Usero L, et al. Among authors: miralles l. J Immunol Methods. 2021 Nov;498:113133. doi: 10.1016/j.jim.2021.113133. Epub 2021 Sep 2. J Immunol Methods. 2021. PMID: 34480950 Free article.

2

The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses.

Usero L, Leal L, Gómez CE, Miralles L, Aurrecoechea E, Esteban I, Torres B, Inciarte A, Perdiguero B, Esteban M, García F, Plana M. Usero L, et al. Among authors: miralles l. Vaccines (Basel). 2023 Jan 28;11(2):286. doi: 10.3390/vaccines11020286. Vaccines (Basel). 2023. PMID: 36851164 Free PMC article.

3

Utility of Systematic Isolation of immune cell subsets from HIV-infected individuals for miRNA profiling.

Bargalló ME, Guardo AC, Maleno MJ, Miralles L, Egaña-Gorroño L, Escribà T, García F, Gatell JM, Arnedo M, Plana M. Bargalló ME, et al. Among authors: miralles l. J Immunol Methods. 2017 Mar;442:12-19. doi: 10.1016/j.jim.2016.12.005. Epub 2016 Dec 27. J Immunol Methods. 2017. PMID: 28039100

4

Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses.

Climent N, García I, Marradi M, Chiodo F, Miralles L, Maleno MJ, Gatell JM, García F, Penadés S, Plana M. Climent N, et al. Among authors: miralles l. Nanomedicine. 2018 Feb;14(2):339-351. doi: 10.1016/j.nano.2017.11.009. Epub 2017 Nov 20. Nanomedicine. 2018. PMID: 29157976

5

Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial.

Leal L, Couto E, Sánchez-Palomino S, Climent N, Fernández I, Miralles L, Romero Y, González T, Maleno MJ, Paño B, Pich J, Nicolau C, Gatell JM, Plana M, García F; DCV3-RISVAC04 Study Group. Leal L, et al. Among authors: miralles l. Front Immunol. 2021 Nov 11;12:767370. doi: 10.3389/fimmu.2021.767370. eCollection 2021. Front Immunol. 2021. PMID: 34858423 Free PMC article. Clinical Trial.

6

Adenosine deaminase regulates Treg expression in autologous T cell-dendritic cell cocultures from patients infected with HIV-1.

Naval-Macabuhay I, Casanova V, Navarro G, García F, León A, Miralles L, Rovira C, Martinez-Navio JM, Gallart T, Mallol J, Gatell JM, Lluís C, Franco R, McCormick PJ, Climent N. Naval-Macabuhay I, et al. Among authors: miralles l. J Leukoc Biol. 2016 Feb;99(2):349-59. doi: 10.1189/jlb.3A1214-580RR. Epub 2015 Aug 26. J Leukoc Biol. 2016. PMID: 26310829

7

Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV.

Climent N, Martinez-Navio JM, Gil C, Garcia F, Rovira C, Hurtado C, Miralles L, Gatell JM, Gallart T, Mallol J, Lluis C, Franco R. Climent N, et al. Among authors: miralles l. Immunol Cell Biol. 2009 Nov-Dec;87(8):634-9. doi: 10.1038/icb.2009.53. Epub 2009 Aug 11. Immunol Cell Biol. 2009. PMID: 19668260

8

Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.

Gil C, Climent N, García F, Hurtado C, Nieto-Márquez S, León A, García MT, Rovira C, Miralles L, Dalmau J, Pumarola T, Almela M, Martinez-Picado J, Lifson JD, Zamora L, Miró JM, Brander C, Clotet B, Gallart T, Gatell JM. Gil C, et al. Among authors: miralles l. Vaccine. 2011 Aug 5;29(34):5711-24. doi: 10.1016/j.vaccine.2011.05.096. Epub 2011 Jun 14. Vaccine. 2011. PMID: 21679735 Clinical Trial.

9

Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same Antigen.

Gómez CE, Perdiguero B, Usero L, Marcos-Villar L, Miralles L, Leal L, Sorzano CÓS, Sánchez-Corzo C, Plana M, García F, Esteban M. Gómez CE, et al. Among authors: miralles l. Vaccines (Basel). 2021 Aug 27;9(9):959. doi: 10.3390/vaccines9090959. Vaccines (Basel). 2021. PMID: 34579196 Free PMC article.

10

Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix).

Guardo AC, Joe PT, Miralles L, Bargalló ME, Mothe B, Krasniqi A, Heirman C, García F, Thielemans K, Brander C, Aerts JL, Plana M; iHIVARNA consortium. Guardo AC, et al. Among authors: miralles l. AIDS. 2017 Jan 28;31(3):321-332. doi: 10.1097/QAD.0000000000001276. AIDS. 2017. PMID: 27677160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year